Meeting program
3rd EHA-Balkan Hematology Day - Novel Therapies of Lymphoma
09:00 - 09:15 EET Opening remarks
- Welcome of participants
M Pagoni (Hellenic Society of Haematology) & E Terpos (Hellenic Society of Haematology) - History of the meeting
D Coriu (European Hematology Association & Romanian Society of Hematology) - Introduction meeting program
I Baltadakis (Hellenic Society of Haematology) - About HSH & EHA
M Pagoni (Hellenic Society of Haematology) & D Coriu (European Hematology Association & Romanian Society of Hematology)
09:15 - 10:45 EET Session 1: Chronic lymphocytic leukemia (CLL) and Indolent Lymphomas
Chairs: M Guenova (Bulgaria) & M Škerget (Slovenia)
- State-of-the Art: Chronic lymphocytic leukemia (CLL): Selection of The Optimal First-line Treatment
K Stamatopoulos (Greece) - First-line therapy of Chronic lymphocytic leukemia (CLL)
S Sachanas (Greece) - Relapsed Follicular Lymphoma (FL): Current and Emerging Therapies
E Spanoudakis (Greece) - Richter’s Transformation: Which are the Therapeutic Options?
F Gashi (Kosovo)
10:45 - 11:00 EET Coffee break
11:00 - 12:30 EET Session 2: Aggressive Non-Hodgkin Lymphomas
Chairs: M Michael (Cyprus) & P Panayiotidis (Greece)
- State-of-the Art: Novel Off-the-Self Immunotherapies for Diffuse large B-cell lymphoma (DLBCL)
B Ferhanoğlu (Türkiye) - Primary CNS Lymphoma: Is Autologous Transplantation Beneficial?
K Venkov (Bulgaria) - Front-line Therapy for Double and Triple-Hit Lymphomas
OD Preda (Romania) - Peripheral T cell Lymphomas: The Role of Transplantation
A Cili (Albania)
12:30 - 13:30 EET Lunch
13:30 - 15:00 EET Session 3: CAR-T Cell Therapies
Chairs: V Cavolli (Kosovo) & S Badelita (Romania)
- State-of-the Art: CAR-T Cell Therapy in Lymphomas
I Baltadakis (Greece) - CAR-T in Diffuse large B-cell lymphoma (DLBCL)
M Sever (Slovenia) - CAR-T and the treatment of Mantle Cell Lymphoma (MCL)
S Bašić-Kinda (Croatia) - CAR-T in Follicular Lymphoma (FL)
S Ratip (Türkiye)
15:00 - 15:15 EET Coffee break
15:15 - 17:00 EET Session 4: Hodgkin’s Lymphoma (HL)
Chairs: O Mehtap (Türkiye) & G Pangalis (Greece)
- State-of-the Art: First-Line Therapy of Hodgkin's Lymphoma (HL): The Role of Novel Agents
T Vassilakopoulos (Greece) - The role of Interim PET
A Agathocleous (Cyprus) - Prioritizing Therapeutic Options for Primary Refractory Hodgkin's Lymphoma (HL)
S Buruiana (Moldova) - Management of Relapsed Hodgkin's Lymphoma (HL) After Autologous Transplantation
M Tsirogianni (Greece) - Management of advanced stage HL: Initial therapy and beyond
I Urosevic (Serbia)
17:00 - 17:30 EET EHA Lighting the Flame & Regional Collaboration Session
Chairs: H Parker (European Hematology Association), M Pagoni (Hellenic Society of Haematology) & C Matsouka (Hellenic Society of Haematology)
- EHA Lighting the Flame
M Nikolaidou (European Hematology Association) & E Solomou (Greece) - HSH & EHA collaboration
Maria Pagoni (Hellenic Society of Haematology) & E Papadaki (Greece) - Regional (Balkan) collaboration opportunities and involvement within EHA
H Parker (European Hematology Association)
17:30 - 17:45 EET Closing remarks
- Thank you & goodbye by meeting chairs
M Pagoni (Hellenic Society of Haematology), I Baltadakis (Hellenic Society of Haematology), D Coriu (European Hematology Association & Romanian Society of Hematology) & E Terpos (Hellenic Society of Haematology)
Back